A conference focused on advancing engineered vision technologies.
Official title: Engineered Vision Conference (EVC)
Funded at University of Southern California · NIH-11002904 · Data updated 2026-11-12
The Engineered Vision Conference is a friendly gathering where top experts come together to share ideas and solutions about new technologies that could help improve vision, focusing on things like electronic devices, cell treatments, and gene therapies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project start | July 22, 2024 |
| Project end | July 21, 2025 |
| Funding year | 2024 |
| Award (this year) | $51,750 |
| NIH project number | 1R13EY036745-01 |
| Project ID | NIH-11002904 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals affected by vision loss or blindness who are interested in emerging therapies.
✕Less likely to help
Patients with stable vision or those not affected by vision-related conditions may not receive direct benefits from this research.
What this research studies
The Engineered Vision Conference (EVC) aims to bring together leading experts in vision research, cell and gene therapy, and biomedical engineering to discuss advancements in engineered vision technologies. The conference will focus on three main areas: bioelectronic devices, cell-based therapies, and gene therapies, addressing common engineering challenges and clinical endpoints. Participants will collaborate to identify obstacles in these fields and develop strategic plans to overcome them, fostering innovation and potential breakthroughs in vision restoration and enhancement.
Why it matters
Potential benefit: If successful, this research could lead to significant advancements in treatments for vision impairment and blindness.
How similar studies have gone: Previous conferences and collaborations in related fields have successfully advanced technologies and therapies, indicating a promising potential for this initiative.
Where this research is happening
-
University of Southern California
Los Angeles, United States Active
Researchers
- Principal investigator: Humayun, Mark S — University of Southern California
- Study coordinator: Humayun, Mark S
Related research
Other NIH-funded projects on the same topics.
-
RNA dysregulation in a rare childhood brain disorder (PCH1b)
Researchers are studying a rare genetic brain disease in young children to understand how RNA processing goes wrong and leads to damage in the cerebellum and brainstem.
-
Studying how diverse signals come from similar molecules at glutamatergic synapses
A project at a university explores how synapses in the brain create different signals from a shared set of molecules, using a fruit-fly model to understand how this could relate to neurodevelopmental and neurodegenerative diseases.
-
How brain chemicals may influence tau clumps in Alzheimer’s disease
A study from USC explores how certain brain chemicals might influence the clumping of tau protein related to Alzheimer’s disease, aiming to identify factors that could affect disease progression.
-
GLP-1 medicines and brain health: real-world clues about dementia risk
A nationwide study will follow adults 21 and older using GLP-1 medicines to see how these drugs relate to memory, thinking, and dementia risk in real life.
-
Male pesticide exposure and reproductive health through epigenetics
This project looks at how a man’s exposure to pesticides might affect his fertility and the health of his future children through changes in DNA.
-
Global effort to harmonize fMRI findings in psychiatry
A large, international effort will standardize how brain MRI data are collected and analyzed in people with various mental health conditions to improve consistency and discovery.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.